Balanced Fluids for Pediatric Sepsis
(PRoMPT BOLUS Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests different fluids to determine which is safer and more effective for treating septic shock in children. Researchers compare balanced fluids, such as Lactated Ringer's or Plasma-Lyte, with the standard saline solution to see if they better prevent kidney injury. The trial seeks children between 2 months and 18 years old diagnosed with septic shock who need fluid resuscitation. Participants will receive either the experimental fluids or normal saline, and doctors will closely monitor their progress. As a Phase 3 trial, this study represents the final step before FDA approval, offering participants a chance to contribute to potentially groundbreaking treatment advancements.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on fluid resuscitation for septic shock in children.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that both Lactated Ringer (LR) and Plasma-Lyte are generally safe for children. Studies have found that these balanced fluids do not result in worse outcomes than normal saline when treating children with sepsis. Some research even suggests that Plasma-Lyte might help address issues like acidosis, where the body's acid levels are imbalanced.
Hospitals have used balanced fluids for a long time, and most patients usually tolerate them well. Designed to resemble the body's natural fluids, they may reduce the risk of complications. However, each person may react differently, so healthcare professionals should monitor any treatment.12345Why are researchers excited about this trial's treatments?
Researchers are excited about using balanced fluids like Lactated Ringer's and Plasma-Lyte for pediatric sepsis because they offer a different approach to fluid resuscitation compared to the standard 0.9% "normal" saline. These balanced fluids are designed to more closely mimic the body's natural plasma composition, which may lead to better acid-base balance and less risk of developing complications like acidosis. This could potentially improve outcomes in children with sepsis by stabilizing their condition more effectively and with fewer side effects.
What evidence suggests that this trial's treatments could be effective for pediatric sepsis?
This trial will compare the use of balanced fluids, such as Lactated Ringer's and Plasma-Lyte, with normal saline in children with septic shock. Research has shown that balanced fluids do not always lead to better results compared to normal saline. Some studies found no major differences in outcomes like kidney health or overall recovery. While balanced fluids might help with issues like excess acidity in the body, normal saline remains a common treatment. Overall, the benefits of balanced fluids compared to normal saline in treating children with sepsis remain unclear.12678
Who Is on the Research Team?
Fran Balamuth, MD PhD MSCE
Principal Investigator
Attending Physician, Emergency Department
Are You a Good Fit for This Trial?
This trial is for children aged over 2 months and under 18 years with a physician's diagnosis of septic shock needing antibiotics and fluid resuscitation. It excludes those with certain metabolic disorders, known pregnancy, prisoners, allergies to crystalloid fluids, severe liver or kidney issues, high potassium or calcium levels, or if the clinician deems it unsafe.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either balanced fluids (BF) or 0.9% normal saline (NS) for fluid resuscitation immediately after randomization through the next calendar day
Follow-up
Participants are monitored for safety and effectiveness after treatment, with primary endpoint being major adverse kidney events within 30 days
Extended Follow-up
Participants are monitored for additional outcomes such as all-cause mortality at 90 days
What Are the Treatments Tested in This Trial?
Interventions
- Lactated Ringer
- Normal Saline
- Plasma-lyte
Lactated Ringer is already approved in European Union, United States, Canada, Japan, China, Switzerland for the following indications:
- fluid resuscitation after blood loss due to trauma or surgery
- sepsis
- acute pancreatitis
- burn injuries
- fluid resuscitation after blood loss due to trauma or surgery
- sepsis
- acute pancreatitis
- burn injuries
- fluid resuscitation after blood loss due to trauma or surgery
- sepsis
- acute pancreatitis
- burn injuries
- fluid resuscitation after blood loss due to trauma or surgery
- sepsis
- acute pancreatitis
- burn injuries
- fluid resuscitation after blood loss due to trauma or surgery
- sepsis
- acute pancreatitis
- burn injuries
- fluid resuscitation after blood loss due to trauma or surgery
- sepsis
- acute pancreatitis
- burn injuries
Find a Clinic Near You
Who Is Running the Clinical Trial?
Children's Hospital of Philadelphia
Lead Sponsor
Queensland Children's Hospital
Collaborator
Queen's University
Collaborator
Kingston Health Sciences Centre
Collaborator
Townsville University Hospital
Collaborator
Queensland Children's Hospital
Collaborator
Royal Children's Hospital
Collaborator
The Children's Hospital of Winnipeg
Collaborator
Westmead Children's Hospital
Collaborator
Children's Hospital and Health System Foundation, Wisconsin
Collaborator